tiprankstipranks
Nexeon MedSystems Inc (NXNN)
OTHER OTC:NXNN
US Market
Holding NXNN?
Track your performance easily

Nexeon MedSystems (NXNN) Income Statement

56 Followers

Nexeon MedSystems Income Statement

Last quarter (Q ), Nexeon MedSystems's total revenue was $1.98M, an increase of 90.22% from the same quarter last year. In Q, Nexeon MedSystems's net income was $-1.39M. See Nexeon MedSystems’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 17Dec 16Dec 15
Total Revenue
$ 9.82M$ 3.30M$ 1.49M$ 0.00
Cost of Revenue
$ 6.81M$ 2.32M$ 39.13K-
Gross Profit
$ 3.01M$ 981.02K$ 1.46M-
Operating Expense
$ 8.68M$ 7.07M$ 2.09M$ 915.00
Operating Income
$ -5.67M$ -6.09M$ -634.27K$ -915.00
Net Non Operating Interest Income Expense
$ -321.26K$ -111.93K$ 5.31K$ 0.00
Other Income Expense
$ 3.77M$ 4.03M$ -173.50K-
Pretax Income
$ -2.22M$ -2.18M$ -802.46K$ -915.00
Tax Provision
$ -576.22K-$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -1.65M$ -2.18M$ -802.46K$ -915.00
Basic EPS
$ -0.68$ -1.26$ -1.18$ >-0.01
Diluted EPS
$ -0.68$ -1.26$ -1.18$ >-0.01
Basic Average Shares
$ 7.83M$ 1.78M$ 1.34M$ 1.30M
Diluted Average Shares
$ 7.83M$ 1.78M$ 1.34M$ 1.30M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 15.49M$ 9.39M$ 2.13M$ 915.00
Net Income From Continuing And Discontinued Operation
$ -1.65M$ -2.18M$ -802.46K$ -915.00
Normalized Income
$ -4.31M$ -6.20M$ -628.96K$ -915.00
Interest Expense
$ 318.07K$ 113.97K$ 13.74K$ 0.00
EBIT
$ -1.90M$ -2.06M$ -788.73K$ -915.00
EBITDA
$ -431.01K$ -765.96K$ -151.80K$ -915.00
Currency in USD

Nexeon MedSystems Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis